Asaff Harel

495 total citations
27 papers, 342 citations indexed

About

Asaff Harel is a scholar working on Pathology and Forensic Medicine, Neurology and Infectious Diseases. According to data from OpenAlex, Asaff Harel has authored 27 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pathology and Forensic Medicine, 10 papers in Neurology and 8 papers in Infectious Diseases. Recurrent topics in Asaff Harel's work include Multiple Sclerosis Research Studies (13 papers), SARS-CoV-2 and COVID-19 Research (6 papers) and Peripheral Neuropathies and Disorders (6 papers). Asaff Harel is often cited by papers focused on Multiple Sclerosis Research Studies (13 papers), SARS-CoV-2 and COVID-19 Research (6 papers) and Peripheral Neuropathies and Disorders (6 papers). Asaff Harel collaborates with scholars based in United States, Italy and United Kingdom. Asaff Harel's co-authors include Fred Lublin, Rebecca Straus Farber, Alessandra N. Kazura, Dianne Abuelo, Michelle Fabian, Bidyut K. Pramanik, Matilde Inglese, Igor J. Koralnik, Sylvia Klineova and Arpan Patel and has published in prestigious journals such as PLoS ONE, Neurology and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

Asaff Harel

21 papers receiving 341 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Asaff Harel United States 11 209 109 72 70 54 27 342
Salim Chahin United States 14 339 1.6× 158 1.4× 65 0.9× 42 0.6× 19 0.4× 28 460
Valeria Barcella Italy 8 238 1.1× 98 0.9× 56 0.8× 49 0.7× 31 0.6× 15 367
Lynn Stazzone United States 9 431 2.1× 152 1.4× 91 1.3× 34 0.5× 50 0.9× 10 530
D. Carrara Italy 5 309 1.5× 147 1.3× 57 0.8× 24 0.3× 57 1.1× 5 440
A. Bellacosa Italy 8 411 2.0× 175 1.6× 80 1.1× 26 0.4× 60 1.1× 8 548
Augusto Miravalle United States 10 412 2.0× 155 1.4× 208 2.9× 41 0.6× 21 0.4× 28 629
Maria Cellerino Italy 11 299 1.4× 147 1.3× 52 0.7× 37 0.5× 32 0.6× 41 396
P. Adam Czechia 9 121 0.6× 115 1.1× 37 0.5× 29 0.4× 16 0.3× 26 293
Ann Marie Weideman United States 8 252 1.2× 68 0.6× 57 0.8× 26 0.4× 7 0.1× 24 359
Ana‐Luiza Sayao Canada 11 313 1.5× 98 0.9× 40 0.6× 49 0.7× 29 0.5× 19 455

Countries citing papers authored by Asaff Harel

Since Specialization
Citations

This map shows the geographic impact of Asaff Harel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asaff Harel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asaff Harel more than expected).

Fields of papers citing papers by Asaff Harel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Asaff Harel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asaff Harel. The network helps show where Asaff Harel may publish in the future.

Co-authorship network of co-authors of Asaff Harel

This figure shows the co-authorship network connecting the top 25 collaborators of Asaff Harel. A scholar is included among the top collaborators of Asaff Harel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Asaff Harel. Asaff Harel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Harel, Asaff, et al.. (2025). Retinal Vasculitis as an Initial Presentation of Atypical Neurosarcoidosis With Occult Central Nervous System Inflammation. Journal of VitreoRetinal Diseases. 10(1). 166–172.
3.
Harel, Asaff, et al.. (2024). Profile of Ofatumumab in the Treatment of Multiple Sclerosis: Design, Development and Place in Therapy. Drug Design Development and Therapy. Volume 18. 5985–5996.
4.
5.
6.
Stern, Joel N. H., et al.. (2023). Post-vaccination SARS-Cov-2 T-cell receptor repertoires in patients with multiple sclerosis and related disorders. Multiple Sclerosis and Related Disorders. 79. 104965–104965. 4 indexed citations
7.
Harel, Asaff, et al.. (2022). Lifestyle Measures in Multiple Sclerosis. 18(2). 122–122. 1 indexed citations
8.
Ballout, Ahmad A., et al.. (2022). A Single-Health System Case Series of New-Onset CNS Inflammatory Disorders Temporally Associated With mRNA-Based SARS-CoV-2 Vaccines. Frontiers in Neurology. 13. 796882–796882. 9 indexed citations
9.
Klineova, Sylvia, Asaff Harel, Rebecca Straus Farber, et al.. (2021). Outcomes of COVID-19 infection in multiple sclerosis and related conditions: One-year pandemic experience of the multicenter New York COVID-19 Neuroimmunology Consortium (NYCNIC). Multiple Sclerosis and Related Disorders. 55. 103153–103153. 12 indexed citations
10.
11.
Laurent, Micheline N., et al.. (2021). Defining the role of T lymphocytes in the immunopathogenesis of neuromyelitis optica spectrum disorder.. Discovery Medicine. 29(157). 91–102. 5 indexed citations
12.
Klineova, Sylvia, et al.. (2020). COVID-19 infection in patients with multiple sclerosis: an observational study by the New York COVID-19 neuroimmunology consortium (NYCNIC). Multiple Sclerosis Journal. 26. 78–78. 3 indexed citations
13.
Harel, Asaff, et al.. (2020). Negative SARS-CoV-2 antibody testing following COVID-19 infection in Two MS patients treated with ocrelizumab. Multiple Sclerosis and Related Disorders. 44. 102341–102341. 45 indexed citations
14.
15.
Harel, Asaff, Maria Petracca, Stephen Krieger, et al.. (2018). Brain microstructural injury occurs in patients with RRMS despite ‘no evidence of disease activity’. Journal of Neurology Neurosurgery & Psychiatry. 89(9). 977–982. 16 indexed citations
16.
Cocozza, Sirio, Maria Petracca, Enricomaria Mormina, et al.. (2017). Cerebellar lobule atrophy and disability in progressive MS. Journal of Neurology Neurosurgery & Psychiatry. 88(12). 1065–1072. 51 indexed citations
17.
Pardini, Matteo, Maria Petracca, Asaff Harel, et al.. (2017). The relationship between cortical lesions and periventricular NAWM abnormalities suggests a shared mechanism of injury in primary-progressive MS. NeuroImage Clinical. 16. 111–115. 12 indexed citations
18.
19.
Harel, Asaff, Antonia Ceccarelli, Colleen Farrell, et al.. (2016). Phase-Sensitive Inversion-Recovery MRI Improves Longitudinal Cortical Lesion Detection in Progressive MS. PLoS ONE. 11(3). e0152180–e0152180. 16 indexed citations
20.
Harel, Asaff, Dianne Abuelo, & Alessandra N. Kazura. (2003). Adolescents and genetic testing: what do they think about it?. Journal of Adolescent Health. 33(6). 489–494. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Salim Chahin Breakdown of academic impact, for papers by Valeria Barcella Breakdown of academic impact, for papers by Lynn Stazzone Breakdown of academic impact, for papers by D. Carrara Breakdown of academic impact, for papers by A. Bellacosa Breakdown of academic impact, for papers by Augusto Miravalle Breakdown of academic impact, for papers by Maria Cellerino Breakdown of academic impact, for papers by P. Adam Breakdown of academic impact, for papers by Ann Marie Weideman Breakdown of academic impact, for papers by Ana‐Luiza Sayao
Rankless by CCL
2026